Study Links Early Infections to Celiac Risk
Children who have a lot of infections in the first 18 months of life may have an increased risk for celiac disease, a new...
Higher-Volume Rehab Centers Better for Hip Fracture Recovery: Study
Seniors who break a hip receive the best care in skilled nursing facilities with the most experience handling such fractures, a new study suggests....
Keytruda Approved for Leading Form of Lung Cancer
Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced cases of the most common type of lung malignancy,...
ABBVIE ANNOUNCES SUBMISSION OF A SUPPLEMENTAL NEW DRUG APPLICATION FOR IMBRUVICA® (IBRUTINIB) FOR TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA
a global biopharmaceutical company, announced today that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) based...
Bayer aligns organization with Life Science businesses
Operational management in three divisions: Pharmaceuticals, Consumer Health and Crop Science / Dieter Weinand, Erica Mann and Liam Condon appointed to the Bayer...
Merck Provides Diabetes Portfolio Update and Underscores Comprehensive, Long-Term Commitment to Patients with Diabetes
Presents Pivotal Data for Omarigliptin, Merck’s Investigational Once-Weekly DPP-4 Inhibitor, and Additional Data from the TECOS CV Safety Trial, at European Association for the...
Bristol-Myers Squibb to Take Part in Deutsche Bank Global Health Care Conference
Bristol-Myers Squibb to Take Part in Deutsche Bank Global Health Care Conference 4/29/15 will take part in the Deutsche Bank Global Health Care Conference on...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...